Low Phase Angle is Associated with the Development of Hepatic Encephalopathy in Patients with Cirrhosis
Overview
Authors
Affiliations
Aim: Evaluate the association between phase angle and the development of hepatic encephalopathy in the long-term follow-up of cirrhotic patients.
Methods: This was a prospective cohort study. Clinical, nutritional and biochemical evaluations were performed. Mann-Whitney's and χ tests were used as appropriate. Kaplan-Meier curves and Cox proportional Hazards analysis were used to evaluate the prediction and incidence of hepatic encephalopathy.
Results: Two hundred and twenty were included; the most frequent etiology of cirrhosis was hepatitis C infection, 52% of the patients developed hepatic encephalopathy (18.6% covert and 33.3% overt); the main precipitating factors were infections and variceal bleeding. Kaplan-Meier curves showed a higher proportion of HE in the group with low phase angle (39%) compared to the normal phase angle group (13%) ( = 0.012). Furthermore, creatinine and phase angle remained independently associated to hepatic encephalopathy in the Cox regression multivariate analysis [hazard ratio = 1.80 (1.07-3.03)].
Conclusion: In our cohort of patients low phase angle was associated with an increased incidence of hepatic encephalopathy. Phase angle is a useful nutritional marker that evaluates cachexia and could be used as a part of the integral assessment in patients with cirrhosis.
Hepatic encephalopathy: risk identification and prophylaxis approaches.
Torre A, Cordova-Gallardo J, Martinez-Sanchez F Metab Brain Dis. 2025; 40(3):138.
PMID: 40053146 DOI: 10.1007/s11011-025-01531-y.
Quantitative Assessment of Body Composition in Cirrhosis.
Eriksen C, Moller S Diagnostics (Basel). 2024; 14(19).
PMID: 39410594 PMC: 11482591. DOI: 10.3390/diagnostics14192191.
Sepehrinezhad A, Moghaddam N, Shayan N, Negah S PLoS One. 2024; 19(9):e0307899.
PMID: 39226259 PMC: 11371226. DOI: 10.1371/journal.pone.0307899.
Alves V, Giesta J, Bosa V, Goldani H J Pediatr (Rio J). 2024; 100(5):491-497.
PMID: 38614136 PMC: 11361877. DOI: 10.1016/j.jped.2023.12.006.
Optimizing nutrition in hepatic cirrhosis: A comprehensive assessment and care approach.
Mendez-Guerrero O, Carranza-Carrasco A, Chi-Cervera L, Torre A, Navarro-Alvarez N World J Gastroenterol. 2024; 30(10):1313-1328.
PMID: 38596498 PMC: 11000076. DOI: 10.3748/wjg.v30.i10.1313.